162
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness of blood culture and a multiplex real-time PCR in hematological patients with suspected sepsis: an observational propensity score-matched study

, , , , , , , , , , , , , , , , , & show all

References

  • Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348(16):1546-54
  • Ginde AA, Moss M, Shapiro NI, Schwartz RS. Impact of older age and nursing home residence on clinical outcomes of US emergency department visits for severe sepsis. J Crit Care 2013;28(5):606-11
  • Lagu T, Rothberg MB, Shieh MS, et al. What is the best method for estimating the burden of severe sepsis in the United States? J Crit Care 2012;27(4):414 e411-419
  • Hall MJ, Williams SN, Defrances CJ, Golosinkiy A. Inpatient care for septicemia or sepsis: a challenge for patients and hospitals. NCHS Data Brief 2011;62:1-8
  • Wang HE, Shapiro NI, Angus DC, Yealy DM. National estimates of severe sepsis in United States emergency departments. Crit Care Med 2007;35(8):1928-36
  • Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007;35(5):1244-50
  • Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41(2):580-637
  • Uittenbogaard AJ, De Deckere ER, Sandel MH, et al. Impact of the diagnostic process on the accuracy of source identification and time to antibiotics in septic emergency department patients. Eur J Emerg Med 2013. [Epub ahead of print]
  • Conde KA, Silva E, Silva CO, et al. Differences in sepsis treatment and outcomes between public and private hospitals in brazil: a multicenter observational study. PLoS One 2013;8(6):e64790
  • Cornaglia G, Giamarellou H, Rossolini GM. Metallo-beta-lactamases: a last frontier for beta-lactams? Lancet Infect Dis 2011;11(5):381-93
  • Burchardi H, Schneider H. Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy. Pharmacoeconomics 2004;22(12):793-813
  • Moerer O, Plock E, Mgbor U, et al. A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units. Crit Care 2007;11(3):R69
  • Chalupka AN, Talmor D. The economics of sepsis. Crit Care Clin 2012;28(1):57-76, vi
  • Reinhart K, Bauer M, Riedemann NC, Hartog CS. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev 2012;25(4):609-34
  • Mancini N, Carletti S, Ghidoli N, et al. The era of molecular and other non-culture-based methods in diagnosis of sepsis. Clin Microbiol Rev 2010;23(1):235-51
  • Mancini N, Clerici D, Diotti R, et al. Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies. J Med Microbiol 2008;57(Pt 5):601-4
  • Tissari P, Zumla A, Tarkka E, et al. Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study. Lancet 2010;375(9710):224-30
  • Jordana-Lluch E, Carolan HE, Gimenez M, et al. Rapid diagnosis of bloodstream infections with PCR followed by mass spectrometry. PLoS One 2013;8(4):e62108
  • Paolucci M, Stanzani M, Melchionda F, et al. Routine use of a real-time polymerase chain reaction method for detection of bloodstream infections in neutropaenic patients. Diagn Microbiol Infect Dis 2013;75(2):130-4
  • Dark P, Dunn G, Chadwick P, et al. The clinical diagnostic accuracy of rapid detection of healthcare-associated bloodstream infection in intensive care using multipathogen real-time PCR technology. BMJ Open 2011;1(1):e000181
  • Mancini N, Poloniato A, Ghidoli N, et al. Potential role of the detection of enterobacterial DNA in blood for the management of neonatal necrotizing enterocolitis. J Med Microbiol 2012;61(Pt 10):1465-72
  • Mato A, Fuchs BD, Heitjan DF, et al. Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignancies. Cancer Biol Ther 2009;8(12):1095-100
  • Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 2011;10(2):150-61
  • Caselli D, Cesaro S, Ziino O, et al. A prospective, randomized study of empirical antifungal therapy for the treatment of chemotherapy-induced febrile neutropenia in children. Br J Haematol 2012;158(2):249-55
  • Gristina GR, Antonelli M, Conti G, et al. Noninvasive versus invasive ventilation for acute respiratory failure in patients with hematologic malignancies: a 5-year multicenter observational survey. Crit Care Med 2011;39(10):2232-9
  • Mclaughlin AM, Hardt J, Canavan JB, Donnelly MB. Determining the economic cost of ICU treatment: a prospective "micro-costing" study. Intensive Care Med 2009;35(12):2135-40
  • Bates DW, Yu DT, Black E, et al. Resource utilization among patients with sepsis syndrome. Infect Control Hosp Epidemiol 2003;24(1):62-70
  • Lagu T, Rothberg MB, Nathanson BH, et al. The relationship between hospital spending and mortality in patients with sepsis. Arch Intern Med 2011;171(4):292-9
  • Morrissey CO, Chen SC, Sorrell TC, et al. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. Lancet Infect Dis 2013;13(6):519-28
  • Vandijck DM, Depaemelaere M, Labeau SO, et al. Daily cost of antimicrobial therapy in patients with Intensive Care Unit-acquired, laboratory-confirmed bloodstream infection. Int J Antimicrob Agents 2008;31(2):161-5
  • Bloos F, Bayer O, Sachse S, et al. Attributable costs of patients with candidemia and potential implications of polymerase chain reaction-based pathogen detection on antifungal therapy in patients with sepsis. J Crit Care 2013;28(1):2-8
  • Fattore G, Jommi C. The last decade of Italian pharmaceutical policy: instability or consolidation? Pharmacoeconomics 2008;26(1):5-15

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.